На главную
Результаты поиска “Opticlick for lantus and apidra”
Intro Opticlick
Intro Pre Introducción al funcionamiento de opticlick
Просмотров: 815 mshcd
new aventis opticlik insulin pen 2017
CONTINUE WATCHING: https://goo.gl/Wk3nTi?60216
Просмотров: 23 Кирилл Миронов
Optipen Pro sample
Просмотров: 302 Gizmo Animation
Lantus injection
11-11-11 I wasn't doing this... 1 year later and it seems like I've been doing this forever!
Просмотров: 408 whaley0320
2011 U.S. Diabetes Injection Pens’ Features [SAMPLE]
1. 2011 U.S. Diabetes Injection Pens' Features N9CF August 2011 2. Disclaimer Frost & Sullivan assumes no liability for any off base data supplied to us by producers or clients. Quantitative business sector data is built basically in light of meetings and in this way is liable to variance. Ice & Sullivan exploration administrations are restricted distributions containing significant business data gave to a select gathering of clients because of requests. Our clients recognize when requesting that Frost & Sullivan exploration administrations are for our clients' inner utilization and not for general distribution or exposure to outsiders. No some piece of this exploration administration may be given, loaned, exchanged, or revealed to non-clients without composed consent. Moreover, no part may be repeated, put away in a recovery framework, or transmitted in any structure or by any methods, electronic, mechanical, photocopying, recording, or overall, without the authorization of the distributer. For data with respect to authorization, keep in touch with: Frost & Sullivan 331 E. Evelyn Ave. Suite 100 Mt. View, CA 94041© 2010 Frost & Sullivan. All rights held. This record contains exceedingly private data and is the sole property of Frost & Sullivan. No some piece of it might be coursed, cited, replicated or generally duplicated without the composed endorsement of Frost & Sullivan.M5E9-15 2 3. Certification• We thusly ensure that the perspectives communicated in this exploration benefit precisely mirror our perspectives in light of essential and optional examination with industry members, industry specialists, end clients, administrative associations, money related and speculation group, and other related sources.• notwithstanding the over, our strong in- house estimate & benchmarking models alongside the Frost & Sullivan Decision Support Databases have been instrumental in the finish and distributed of this report.• We additionally confirm that no a piece of our examiner pay was, is or will be, straightforwardly or in a roundabout way, identified with the particular proposals or perspectives communicated in this service. 4. Table of Contents? Table of Contents Slide 4 ?Research Background, Objectives, Method Details, and Demographics Slide 5 ?Executive Summary Slide 11 ?Primary Injection Pen Brand Usage Slide 18 ?Lantus SoloSTAR Pen Details Slide 21 ?NovoLog Flex Pen Details Slide 25 ?Byetta Pen Details Slide 29 ?Humalog KwikPen Details Slide 33 ?Humulin Pen Details Slide 37 ?NovoPen 3 Details Slide 41 ?SymlinPen Details Slide 49 ?NovoPen 3 PenMate Details Slide 53 ?OptiClik Pen Details Slide 57 ?About Frost & Sullivan Slide 61 5. Chapter by chapter list (continued)? Table of Contents Slide 4 ?Research Background Slide 6 ?Research Objectives Slide 7?Method Details Slide 8 ?Demographics Slide 9?Executive Summary Slide 11 ?Executive Summary Slide 12? Primary Injection Pen Brand Usage Slide 18 ?Top Ten Injection Pen Brands Currently Used Slide 19 ?Satisfaction with Current Brand Slide 20 6. Chapter by chapter list (continued)? Lantus SoloSTAR Pen Details Slide 21 ?Perceived Versus Actual Features: Lantus SoloSTAR Pen Slide 22 ?Satisfaction and Future Intentions: Lantus SoloSTAR Pen Slide 23 ?Lantus SoloSTAR Pen Summary Slide 24? NovoLog Flex Pen Details Slide 25 ?Perceived Versus Actual Features: NovoLog Flex Pen Slide 26 ?Satisfaction and Future Intentions: NovoLog Flex Pen Slide 27 ?NovoLog Flex Pen Summary Slide 28? Byetta Pen Details Slide 29 ?Perceived Versus Actual Features: Byetta Pen Slide 30 ?Satisfaction and Future Intentions: Byetta Pen Slide 31 ?Byetta Pen Summary Slide 32 7. Chapter by chapter list (continued)? Humalog KwikPen Details Slide 33 ?Perceived Versus Actual Features: Humalog KwikPen Slide 34 ?Satisfaction and Future Intentions: Humalog KwikPen Slide 35 ?Humalog KwikPen Summary Slide 36? Humulin Pen Details Slide 37 ?Perceived Versus Actual Features: Humulin Pen Slide 38 ?Satisfaction and Future Intentions: Humulin Pen Slide 39 ?Humulin Pen Summary Slide 40? NovoPen 3 Details Slide 41 ?Perceived Versus Actual Features: NovoPen 3 Slide 42 ?Satisfaction and Future Intentions: NovoPen 3 Slide 43 ?NovoPen 3 Summary Slide 44
Просмотров: 27 DailySlides
Dynamische Elektrochemie - BGStar® & iBGStar® van Sanofi Aventis
Wilt u meer regie over uw leven met diabetes? Sanofi-aventis introduceert de innovatieve BGStar® en iBGStar® bloedglucosemeters, ontworpen door naar de behoeften en verlangens van mensen met diabetes te luisteren. Twee producten voorzien van de meest innovatieve technologie van de 21e eeuw, beiden met een range aan ondersteunende diensten. Om te zorgen voor nauwkeurige meetresultaten, wordt zowel bij de BGStar® als de iBGStar® gebruikgemaakt van Dynamische Elektrochemie. Kijk op www.bgstar.nl wat de BGStar® voor u kan doen.
Просмотров: 1130 gezondheidbovenalles